BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15049509)

  • 1. Tetrapeptides on N- and C-terminal regions of mastoparan inhibit catecholamine release from chromaffin cells by blocking nicotinic acetylcholine receptor.
    Monoi N; Usui M; Takahashi S; Ito H; Kumakura K; Kasai H
    Cell Mol Neurobiol; 2004 Feb; 24(1):37-50. PubMed ID: 15049509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mastoparan on catecholamine release from chromaffin cells.
    Wilson SP
    FEBS Lett; 1989 Apr; 247(2):239-41. PubMed ID: 2714434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors.
    Brindley RL; Bauer MB; Hartley ND; Horning KJ; Currie KPM
    J Neurochem; 2017 Oct; 143(2):171-182. PubMed ID: 28815595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibogaine selectively inhibits nicotinic receptor-mediated catecholamine release.
    Schneider AS; Nagel JE; Mah SJ
    Eur J Pharmacol; 1996 Dec; 317(2-3):R1-2. PubMed ID: 8997631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
    Mahapatra NR; Mahata M; Mahata SK; O'Connor DT
    J Hypertens; 2006 May; 24(5):895-904. PubMed ID: 16612252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor protection studies to characterize neuronal nicotinic receptors: tubocurarine prevents alkylation of adrenal nicotinic receptors.
    Free RB; McKay DB
    Brain Res; 2001 Feb; 891(1-2):176-84. PubMed ID: 11164821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of nicotinic cholinergic receptors by proadrenomedullin N-terminal 12 peptide in bovine adrenal chromaffin cells.
    Kobayashi H; Yamamoto R; Kitamura K; Kuwasako K; Minami S; Yanagita T; Shiraishi S; Yokoo H; Eto T; Wada A
    Brain Res Mol Brain Res; 2001 Mar; 87(2):175-83. PubMed ID: 11245919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade by agmatine of catecholamine release from chromaffin cells is unrelated to imidazoline receptors.
    Santos WC; Hernández-Guijo JM; Ruiz-Nuño A; Olivares R; Jurkiewicz A; Gandía L; García AG
    Eur J Pharmacol; 2001 Apr; 417(1-2):99-109. PubMed ID: 11301064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of lobeline on catecholamine release from the isolated perfused rat adrenal gland.
    Lim DY; Kim YS; Miwa S
    Auton Neurosci; 2004 Jan; 110(1):27-35. PubMed ID: 14766322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncompetitive inhibition by camphor of nicotinic acetylcholine receptors.
    Park TJ; Seo HK; Kang BJ; Kim KT
    Biochem Pharmacol; 2001 Apr; 61(7):787-93. PubMed ID: 11274963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by pregnenolone sulfate of nicotinic acetylcholine response in adrenal chromaffin cells.
    Kudo K; Tachikawa E; Kashimoto T
    Eur J Pharmacol; 2002 Dec; 456(1-3):19-27. PubMed ID: 12450565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the functional subunit combination of nicotinic acetylcholine receptors in bovine adrenal chromaffin cells.
    Tachikawa E; Mizuma K; Kudo K; Kashimoto T; Yamato S; Ohta S
    Neurosci Lett; 2001 Oct; 312(3):161-4. PubMed ID: 11602335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibogaine acts at the nicotinic acetylcholine receptor to inhibit catecholamine release.
    Mah SJ; Tang Y; Liauw PE; Nagel JE; Schneider AS
    Brain Res; 1998 Jun; 797(1):173-80. PubMed ID: 9630615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors and receptor modulation in cultured chromaffin cells.
    Livett BG; Boksa P
    Can J Physiol Pharmacol; 1984 Apr; 62(4):467-76. PubMed ID: 6203633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyl benzyl phthalate blocks Ca2+ signaling and catecholamine secretion coupled with nicotinic acetylcholine receptors in bovine adrenal chromaffin cells.
    Liu PS; Lin CM; Pan CY; Kao LS; Tseng FW
    Neurotoxicology; 2003 Jan; 24(1):97-105. PubMed ID: 12564386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic and muscarinic components in acetylcholine stimulation of porcine adrenal medullary cells.
    Nassar-Gentina V; Catalán L; Luxoro M
    Mol Cell Biochem; 1997 Apr; 169(1-2):107-13. PubMed ID: 9089637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
    Mahata SK; O'Connor DT; Mahata M; Yoo SH; Taupenot L; Wu H; Gill BM; Parmer RJ
    J Clin Invest; 1997 Sep; 100(6):1623-33. PubMed ID: 9294131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-conotoxin ImI inhibits the alpha-bungarotoxin-resistant nicotinic response in bovine adrenal chromaffin cells.
    Broxton NM; Down JG; Gehrmann J; Alewood PF; Satchell DG; Livett BG
    J Neurochem; 1999 Apr; 72(4):1656-62. PubMed ID: 10098874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of nicotinic acetylcholine receptors and calcium channels by clozapine in bovine adrenal chromaffin cells.
    Park T; Bae S; Choi S; Kang B; Kim K
    Biochem Pharmacol; 2001 Apr; 61(8):1011-9. PubMed ID: 11286992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity studies with ring E analogues of methyllycaconitine on bovine adrenal alpha3beta4* nicotinic receptors.
    Bryant DL; Free RB; Thomasy SM; Lapinsky DJ; Ismail KA; McKay SB; Bergmeier SC; McKay DB
    Neurosci Res; 2002 Jan; 42(1):57-63. PubMed ID: 11814609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.